Confirm delete?

Bertin Bioreagent
logo
All categories
Contact Us
You are here :

Lyso-Monosialoganglioside GM1 (ammonium salt)

  • Zoom
    Lyso-Monosialo<wbr/>ganglioside G<sub>M1</sub> (ammonium salt)
  • Lyso-Monosialo<wbr/>ganglioside G<sub>M1</sub> (ammonium salt)
Cat No: 24837
Biochemicals - Lipids
Cayman

Lyso-monosialoganglioside GM1 (Lyso-GM1) is a form of ganglioside GM1 (Item No. 19579) that is lacking the fatty acyl group. Lyso-GM1 (2.5 µM) inhibits laminin-1-induced clustering of ganglioside GM1 in dorsal root ganglion (DRG) cells and also disrup...

More
: 500 µg

This product can only be bought through Cayman Chemical. Please contact us.

Territorial Availability: Available through Bertin Technologies only in France
Synonyms:
  • (2S,3R,4E)-2-amino-3-hydroxy-4-octadecenyl O-(N-acetyl-?-neuraminosyl)-(2?3)-O-[O-?-D-galactopyranosyl-(1?3)-2-(acetylamino)-2-deoxy-?-D-galactopyranosyl-(1?4)]-O-?-D-galactopyranosyl-(1?4)-?-D-glucopyranoside, monoammonium salt
Correlated keywords:
  • 171483-40-2 94458-59-0 146196-34-1 GM-1 LysoGM1 G-M1 ?-1
Product Overview:
Lyso-monosialoganglioside GM1 (Lyso-GM1) is a form of ganglioside GM1 (Item No. 19579) that is lacking the fatty acyl group. Lyso-GM1 (2.5 µM) inhibits laminin-1-induced clustering of ganglioside GM1 in dorsal root ganglion (DRG) cells and also disrupts β1 integrin clustering and neurite outgrowth.{38938} It does not protect against glutamate-induced neurotoxicity in primary neuronal cultures.{38939} Elevated levels of lyso-GM1 have been found in the brain and spinal cord of patients with infantile- and late-infantile-type GM1-gangliosidosis, a neurodegenerative disorder characterized by deficiency of the enzyme β-galactosidase and accumulation of gangliosides.{38940} [Matreya, LLC. Catalog No. 1518]
Size 500 µg
Shipping dry ice
Molecular Formula C55H96N3O30 • NH4
SMILES N[C@H]([C@H](O)/C=C/CCCCCCCCCCCCC)CO[C@@H]1O[C@@H]([C@H]([C@@H]([C@H]1O)O)O[C@@]2([H])[C@@H]([C@@]([C@H]([C@H](O2)CO)O[C@]3([H])O[C@@H]([C@@H]([C@@H]([C@H]3NC(C)=O)O[C@@]4([H])[C@@H]([C@H]([C@H]([C@H](O4)CO)O)O)O)O)CO)([H])O[C@]5(C([O-])=O)C[C@H](O)[C@@H]
Molecular Weight 1297,4
Formulation A solid
Purity ≥98%
Custom Code 2932.99
UNSPSC code 12352100

Click here to ask for your quote and get 15% off Cayman's products.

 

Cayman Chemical's mission is to help make research possible by supplying scientists worldwide with the basic research tools necessary for advancing human and animal health. Our utmost commitment to healthcare researchers is to offer the highest quality products with an affordable pricing policy.

Our scientists are experts in the synthesis, purification, and characterization of biochemicals ranging from small drug-like heterocycles to complex biolipids, fatty acids, and many others. We are also highly skilled in all aspects of assay and antibody development, protein expression, crystallization, and structure determination.

Over the past thirty years, Cayman developed a deep knowledge base in lipid biochemistry, including research involving the arachidonic acid cascade, inositol phosphates, and cannabinoids. This knowledge enabled the production of reagents of exceptional quality for cancer, oxidative injury, epigenetics, neuroscience, inflammation, metabolism, and many additional lines of research.

Our organic and analytical chemists specialize in the rapid development of manufacturing processes and analytical methods to carry out clinical and commercial GMP-API production. Pre-clinical drug discovery efforts are currently underway in the areas of bone restoration and repair, muscular dystrophy, oncology, and inflammation. A separate group of Ph.D.-level scientists are dedicated to offering Hit-to-Lead Discovery and Profiling Services for epigenetic targets. Our knowledgeable chemists can be contracted to perform complete sample analysis for analytes measured by the majority of our assays. We also offer a wide range of analytical services using LC-MS/MS, HPLC, GC, and many other techniques.

Accreditations
ISO/IEC 17025:2005
ISO Guide 34:2009

Cayman is a leader in the field of emerging drugs of abuse, providing high-purity Schedule I-V Controlled Substances to federally-licensed laboratories and qualified academic research institutions for forensic analyses. We are certified by ACLASS Accreditation Services with dual accreditation to ISO/IEC 17025:2005 and ISO Guide 34:2009.

/ We also advise you

Cross selling for this product : Lyso-Monosialo<wbr/>ganglioside G<sub>M1</sub> (ammonium salt) There are 10 products.

Search